Revenue Recognition (Tables)

9 Months Ended

Sep. 30, 2025

The following table summarizes the values of contract assets, capitalized commissions and contract liabilities (in thousands):


	September 30, 2025		December 31, 2024
Current contract assets (1)	$	—	$	100

Total contract assets	$	—	$	100


Current capitalized commissions (1)	$	179	$	206
Long-term capitalized commissions (2)	63		11
Total capitalized commissions	$	242	$	217


Current contract liabilities	$	1,576	$	409
Long-term contract liabilities (3)	507		336
Total contract liabilities	$	2,083	$	745

(1) Recorded within other current assets on the Consolidated Balance Sheets.

(2) Recorded within other assets on the Consolidated Balance Sheets.

(3) Recorded within other long-term liabilities on the Consolidated Balance Sheets.

The following table details the disaggregation of net revenue for the three and nine months ended September 30, 2025 (in thousands):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Client direct billing	$	132,288	$	121,648	$	385,483	$	352,141
Commercial insurance	32,466		24,667		86,089		73,114
Medicare and other government	22,974		21,291		65,462		62,857
Self-pay	69		218		128		454
Total net revenue	$	187,797	$	167,824	$	537,162	$	488,566

NEOGENOMICS INC 10-Q